ENO1 - C-terminal region Antibody from MYBIOSOURCE INC.

Search, find, compare suppliers for anti-ENO1 - C-terminal region antibody, protein, ELISA kits.

Edit 
Antigenic SpecificityENO1 - C-terminal region
Clonepolyclonal
Host SpeciesRabbit
Reactive Speciescow, dog, guinea pig, horse, human, mouse, rabbit, rat, sheep, yeast, zebrafish
Isotypen/a
FormatProtein A purified
Size0.1 mL
Concentrationn/a
ApplicationsImmunohistochemistry (IHC), Western Blot (WB)
Reviews / RatingsIf you have used this antibody, please help fellow researchers by submitting reviews to pAbmAbs and antYbuddY.
DescriptionThis is a rabbit polyclonal antibody against ENO1. It was validated on Western Blot using a cell lysate as a positive control.Target Description: ENO1 is one of three enolase isoenzymes found in mammals; it encodes alpha-enolase, a homodimeric soluble enzyme, and also encodes a shorter monomeric structural lens protein, tau-crystallin. The two proteins are made from the same message. The full length protein, the isoenzyme, is found in the cytoplasm. The shorter protein is produced from an alternative translation start, is localized to the nucleus, and has been found to bind to an element in the c-myc promoter. A pseudogene has been identified that is located on the other arm of the same chromosome.
ImmunogenImmunogen: The immunogen is a synthetic peptide directed towards the C terminal region of human ENO1
Other Names[alpha-enolase isoform 1; alpha-enolase; c-myc promoter-binding protein-1; enolase 1]
Gene, Accession #[ENO1], Gene ID: 2023, NCBI: NP_001419, UniProt: Q53HR3
Catalog #MBS3202020
Price$290
Order / More InfoENO1 - C-terminal region Antibody from MYBIOSOURCE INC.
Product Specific Referencesn/a
MYBIOSOURCE INC.
MYBIOSOURCE INC.
MYBIOSOURCE INC.
P.O. Box 153308
San Diego CA 92195-3308
P: 1.858.633.0165
P: 1.888.MBS.0165 (1.888.627.0165) (US & Canada)
F: 1.858.633.0166

sales@mybiosource.com

http://www.MyBioSource.com

Profile of MYBIOSOURCE INC.
Return to Antibodies

© 1980 - 2024 Linscott's Directory, Linscott's USA. All rights reserved.